Previous Page  13 / 16 Next Page
Information
Show Menu
Previous Page 13 / 16 Next Page
Page Background

Page 34

Notes:

allied

academies

Archives of Industrial Biotechnology | Volume 2

May 14-15, 2018 | Montreal, Canada

World Yeast Congress

T

hecannabinoidsynthaseenzymesTetrahydrocannabinolic

acid (THCA) synthase and Cannabidiolic acid (CBDA)

synthase were recombinantly produced in yeast

Pichia

pastoris

Mut+ strain. The coding regions of THCA synthase

and CBDA synthase genes were codon optimized for

Pichia

expression. Both synthase genes were operably linked to

the methanol inducible AOX1 promoter, an N-terminal alpha

mating factor secretion signal, and a C-terminal 6x His-tag.

These elements provide for inducible expression of the genes

and simple processing/purification of the encoded enzymes.

Each synthase constructwas cloned into Invitrogen’s pPIC3.5K

plasmid. The recombinant plasmids were transformed into

Pichia

strain GS-115.

Pichia

clones transformed with multiple

copies of each construct were selected based on their

resistance to varying amount of geneticin concentrations.

Gene copy numbers were further verified with RT-PCR.

Fermentation conditions were optimized by investigating the

impact of pH, temperature, methanol feed, and fermentation

medium composition on cell growth and enzyme yield. The

fermentation conditions were further optimized in a pilot

scale, 14-liter fermenter. Based on these results, production

was successfully scaled up to 500-liter fermenters. The

Teewinot enzyme production system produced active THCA

synthase and CBDA synthase enzymes. The THCA synthase

converts chemically synthesized CBGA into

9-THCA and

CBCA or chemically synthesized Cannabigerovarinic acid

(CBGVA) into Tetrahydrocannabivarin (THCVA) and CBCVA in

a bioreactor. The ratio of

9-THCA to CBCA and THCVA to

CBCVA is dependent on reaction conditions including pH. The

CBDA synthase enzyme converted chemically synthesized

CBGA into CBDA, CBCA, and THCA or chemically synthesized

CBGVA into CBDVA, CBCVA, and THCVA. Once again, the

molar ratios of CBDA, CBCA, and THCA or the molar ratios

of CBDVA, CBCVA, and THCVA produced in the bioreactor

were dependent on reaction conditions such as pH. Each

of the biocatalytically-produced cannabinoids was purified

to greater than 99.5% purity. The identity and structure of

each biocatalytically-produced cannabinoid was confirmed

by HPLC, mass spectral, and NMR analysis.

Speaker Biography

Mingyang Sun has completed his Master’s Degree in Synthetic Biology from Concordia

University, Montreal. He is a Co-inventor of several US patents on cannabinoid

biosynthesis and the Vice President of Teewinot Laboratories Inc, subsidiary of

Teewinot Life Sciences Corporation.

e:

ming@tlscorp.com

Cannabinoids biosynthesis using recombinant cannabinoid synthase enzymes expressed from

industrial

yeast Pichia pastoris

Mingyang Sun, Oleg Tyurin, Jasleen Bains, Neil Von Wittgenstein, Richard Peet

and

Malcolm Kavarana

Teewinot Life Sciences Corporation, USA